Search results
29 de may. de 2024 · A study of the gaps and opportunities with fusion detection beyond NTRKs on 422 patients from the community. Authors: Hatim Husain, Chaugiang Duong, Steven Rivera, Nathan Montgomery, Roisin Puentes, Derek Lyle, and Fernando J. Lopez-Diaz Authors Info & Affiliations. Publication: Journal of Clinical Oncology.
29 de may. de 2024 · The number of actionable genes beyond those included in the targeted panels were 14 for breast, 2 for brain, 25 for lung, and 41 for colorectal cancer. This underscores the importance of comprehensive testing to fully capture each patient tumor’s actionable mutation profile.
12 de may. de 2024 · Derek Lyle is a Scottish former footballer who played as a striker. Lyle played for Partick Thistle, Queen of the South, Dundee, Hamilton Academical, Greenock Morton, Cowdenbeath, Peterhead and Broomhill.
30 de may. de 2024 · In The Pipeline. Derek Lowe’s commentary on drug discovery and the pharma industry. An editorially independent blog, all content is Derek’s own, and he does not in any way speak for his employer. If you have any questions for Derek, please email him at derekb.lowe@gmail.com. Filters.
Hace 18 horas · Derek Blais represented the parks and recreation department. The committee’s term of office runs for one academic year commencing Sept. 1, 2023. The mock council meeting introduced students to concepts such as advisory reports, creating a notice of motions, voting on active motions, and engaging in debates.
Hace 3 días · NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics.
Hace 3 días · 10 analysts have issued twelve-month target prices for NeoGenomics' shares. Their NEO share price targets range from $17.00 to $26.00. On average, they anticipate the company's share price to reach $19.78 in the next year. This suggests a possible upside of 48.7% from the stock's current price.
